Researchers have been working on a vaccine for respiratory syncytial virus, or RSV, for decades. This week, the first ever RSV vaccine was approved by the U.S. Food and Drug Administration. We speak about that and other potential RSV treatments with Sabina Vohra-Miller, founder of the website Unambiguous Science. For transcripts of this series, please visit: https://www.cbc.ca/radio/podcastnews/the-dose-transcripts-listen-1.6732281